Product Images Torisel

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Torisel NDC 0008-1179 by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - torisel 01

Chemical Structure - torisel 01

Figure 1 - torisel 02

Figure 1 - torisel 02

Logo - torisel 03

Logo - torisel 03

This is a description of a company called Wyeth Pharmaceuticals Inc, which is a subsidiary of Pfizer Inc located in Philadelphia, PA 19101.*

PRINCIPAL DISPLAY PANEL - 25 mg/mL Vial Label - torisel 04

PRINCIPAL DISPLAY PANEL - 25 mg/mL Vial Label - torisel 04

This is a description of Temsirolimus injection, a medication that comes in a single-use vial of 25 mg/mL. The text provides instructions for preparing the medication for IV infusion, including dilution with a specific volume of a diluent and then mixing the solution with sodium chloride injection. The medication needs to be refrigerated and is distributed by Wyeth Pharma.*

PRINCIPAL DISPLAY PANEL - 2.2 mL Vial Label - torisel 05

PRINCIPAL DISPLAY PANEL - 2.2 mL Vial Label - torisel 05

This is a description of a diluent used for the drug TORISEL (temsirolimus) injection. The diluent comes in a 2 mL single-use vial and is only for dilution purposes. The vial should be refrigerated and handled with caution as it is cytotoxic. The usage details can be found in the insert provided. The diluent is made in Italy and should not be directly administered. The text also includes NDC (National Drug Code) numbers for the diluent and TORISEL.*

PRINCIPAL DISPLAY PANEL - Kit Carton - torisel 06

PRINCIPAL DISPLAY PANEL - Kit Carton - torisel 06

This is a description of Torisel, a drug used for intravenous infusion. The package contains 25 mg/mL of temsirolimus injection and an additional diluent of 22 mL. The diluent requires careful handling and refrigeration before administration. The package insert provides instructions for dilution and recommended dosage. It is advised to protect the drug from light. The concentration of the drug is concentrated and requires two dilutions before administration. There is an overfill of 0.2 mL in each vial.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.